pReOperative Dostarlimab and Novel Therapies in EndOmetrial Cancer

NCT07115927 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Endometrial Cancer

Interventions

DRUG: Dostarlimab

Sponsor

University College, London

Collaborators

[object Object]